Vidarabine, also known as 9-β-D-arabinofuranosyladenine, is an antiviral nucleoside analogue used primarily to treat herpes simplex virus infections by inhibiting viral DNA polymerase to prevent viral… Read more
Vidarabine, also known as 9-β-D-arabinofuranosyladenine, is an antiviral nucleoside analogue used primarily to treat herpes simplex virus infections by inhibiting viral DNA polymerase to prevent viral replication. This category offers high-quality reference standards for Vidarabine API, as well as its related impurities and metabolites such as arainosine, which is a known metabolite formed by the deamination of the parent compound. Pharmaceutical laboratories rely on these precise reference materials for rigorous impurity profiling, method validation, and ongoing quality control during drug development and manufacturing processes. Utilizing validated analytical standards, including stable isotope labelled compounds where applicable, ensures the accuracy and reliability of chromatographic testing. These materials are essential for identifying degradation products and monitoring the chemical stability of the drug substance to meet regulatory compliance standards in the analysis of antiviral pharmaceutical formulations.